Contineum Therapeutics, Inc. Class A Common Stock
General ticker "CTNM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $214.5M (TTM average)
Contineum Therapeutics, Inc. Class A Common Stock follows the US Stock Market performance with the rate: 41.6%.
Estimated limits based on current volatility of 3.8%: low 13.72$, high 14.80$
Factors to consider:
- Total employees count: 41 as of 2024
Short-term CTNM quotes
Long-term CTNM plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $50.00MM | $0.00MM |
| Operating Expenses | $22.72MM | $66.08MM | $50.89MM |
| Operating Income | $-22.72MM | $-16.08MM | $-50.89MM |
| Non-Operating Income | $-1.53MM | $39.25MM | $8.64MM |
| Interest Expense | $0.39MM | $0.21MM | $0.00MM |
| R&D Expense | $16.89MM | $27.60MM | $38.16MM |
| Income(Loss) | $-24.25MM | $23.17MM | $-42.26MM |
| Taxes | $0.00MM | $0.45MM | $0.00MM |
| Profit(Loss)* | $-24.25MM | $22.72MM | $-42.26MM |
| Stockholders Equity | $39.27MM | $-67.94MM | $198.07MM |
| Assets | $50.64MM | $130.39MM | $212.85MM |
| Operating Cash Flow | $-20.12MM | $19.35MM | $-32.84MM |
| Capital expenditure | $0.12MM | $0.41MM | $0.51MM |
| Investing Cash Flow | $22.30MM | $-65.57MM | $-69.74MM |
| Financing Cash Flow | $-1.24MM | $56.18MM | $109.00MM |
| Earnings Per Share** | $-0.97 | $0.90 | $-2.18 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.